Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
82.67
-0.23 (-0.28%)
May 4, 2026, 4:00 PM EDT - Market closed
Zimmer Biomet Holdings Employees
Zimmer Biomet Holdings had 17,000 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
17,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$494,653
Profits / Employee
$44,776
Market Cap
15.99B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17,000 | 0 | - |
| Dec 31, 2024 | 17,000 | -1,000 | -5.56% |
| Dec 31, 2023 | 18,000 | 0 | - |
| Dec 31, 2022 | 18,000 | -1,500 | -7.69% |
| Dec 31, 2021 | 19,500 | -500 | -2.50% |
| Dec 31, 2020 | 20,000 | 100 | 0.50% |
| Dec 31, 2019 | 19,900 | 900 | 4.74% |
| Dec 31, 2018 | 19,000 | 800 | 4.40% |
| Dec 31, 2017 | 18,200 | -300 | -1.62% |
| Dec 31, 2016 | 18,500 | 1,000 | 5.71% |
| Dec 31, 2015 | 17,500 | 7,500 | 75.00% |
| Dec 31, 2014 | 10,000 | 500 | 5.26% |
| Dec 31, 2013 | 9,500 | 200 | 2.15% |
| Dec 31, 2012 | 9,300 | 600 | 6.90% |
| Dec 31, 2011 | 8,700 | -100 | -1.14% |
| Dec 31, 2010 | 8,800 | 600 | 7.32% |
| Dec 31, 2009 | 8,200 | -300 | -3.53% |
| Dec 31, 2008 | 8,500 | 900 | 11.84% |
| Dec 31, 2007 | 7,600 | 700 | 10.14% |
| Dec 31, 2006 | 6,900 | 200 | 2.99% |
| Dec 31, 2005 | 6,700 | 100 | 1.52% |
| Dec 31, 2004 | 6,600 | 100 | 1.54% |
| Dec 31, 2003 | 6,500 | 2,900 | 80.56% |
| Dec 31, 2002 | 3,600 | 200 | 5.88% |
| Dec 31, 2001 | 3,400 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 65,340 |
| GE HealthCare Technologies | 54,000 |
| STERIS | 17,787 |
| Smith & Nephew | 16,988 |
| DexCom | 11,100 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
| Insulet | 5,400 |
ZBH News
- 5 days ago - These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results - Benzinga
- 6 days ago - Tariffs Benefit, CFO Exit: What's Going On With Zimmer Biomet Stock On Tuesday? - Benzinga
- 6 days ago - Zimmer Biomet Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Medical device maker Zimmer Biomet raises annual profit forecast, announces CFO departure - Reuters
- 6 days ago - Zimmer Biomet Announces First Quarter 2026 Financial Results - PRNewsWire
- 6 days ago - Zimmer Biomet Announces Chief Financial Officer Transition - PRNewsWire
- 25 days ago - Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results - PRNewsWire
- 27 days ago - Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer - PRNewsWire